Cutaneous Manifestations of Human Immunodeficiency Virus: a Clinical Update

详细信息    查看全文

• 作者：Kirstin Altman (1)
  Erin Vanness (1)
  Ryan P. Westergaard (2) (3)
  
  1. Department of Dermatology ; University of Wisconsin School of Medicine & Public Health ; Madison ; WI ; USA
  2. Departments of Medicine and Population Health Sciences ; University of Wisconsin School of Medicine & Public Health ; Madison ; WI ; USA
  3. Division of Infectious Diseases ; 1685 Highland Ave ; MFCB 5220 ; Madison ; WI ; 53705 ; USA
  
• 关键词：HIV ; Cutaneous disease ; MRSA ; Polyomavirus ; Skin cancer ; SJS/TEN
• 刊名：Current Infectious Disease Reports
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：17
• 期：3
• 全文大小：253 KB
• 参考文献：1. UNAIDS (2012) 鈥楪lobal Report: UNAIDS Report on the Global AIDS Epidemic 2012鈥? http://www.avert.org/worldwide-hiv-aids-statistics.htm
  2. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data鈥擴nited States and 6 U.S. dependent areas鈥?011. HIV Surveillance Supplemental Report 2013;18(No. 5).
  3. CDC. Estimated HIV incidence in the United States, 2007鈥?010. HIV Surveillance Supplemental Report 2012;17(No. 4).
  4. Mankahla, A, Mosam, A (2012) Common skin conditions in children with HIV/AIDS. Am J Clin Dermatol 13: pp. 153-66 2165/11593900-000000000-00000" target="_blank" title="It opens in new window">CrossRef
  5. Cedeno-Laurent, F, G贸mez-Flores, M, Mendez, N, Ancer-Rodr铆guez, J, Bryant, JL, Gaspari, AA (2011) New insights into HIV-1-primary skin disorders. J Int AIDS Soc 14: pp. 5 2652-14-5" target="_blank" title="It opens in new window">CrossRef
  6. Smith, KJ, Skelton, HG, Yeager, J, Ledsky, R, McCarthy, W, Baxter, D (1994) Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol 31: pp. 746-54 22(94)70236-5" target="_blank" title="It opens in new window">CrossRef
  7. Rodgers, S, Leslie, KS (2011) Skin infections in HIV-infected individuals in the era of HAART. Curr Opin Infect Dis 24: pp. 124-9 28342cb31" target="_blank" title="It opens in new window">CrossRef
  8. Bolognia J, Jorizzo J, Schaffer J. Dermatology. 3rd ed. Elsevier; 2012
  9. Kaushik, SB, Cerci, FB, Miracle, J, Pokharel, A, Chen, SC, Chan, YH (2014) Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol 70: pp. 659-64 2013.12.015" target="_blank" title="It opens in new window">CrossRef
  10. Rane SR, Agrawal PB, Kadgi NV, Jadhav MV, Puranik SC. Histopathological study of cutaneous manifestations in HIV and AIDS J Eur Acad Dermatol Venereol. 2013 Feb; 27(2).
  11. Fridkin, SK, Hageman, JC, Morrison, M, Sanza, LT, Como-Sabetti, K, Jernigan, JA (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352: pp. 1436-44 252" target="_blank" title="It opens in new window">CrossRef
  12. Eiff, C, Becker, K, Machka, K, Stammer, H, Peters, G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 344: pp. 11-6 200101043440102" target="_blank" title="It opens in new window">CrossRef
  13. Buehlmann, M, Frei, R, Fenner, L, Dangel, M, Fluckiger, U, Widmer, AF (2008) Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 29: pp. 510-6 201" target="_blank" title="It opens in new window">CrossRef
  14. Popovich, KJ, Weinstein, RA, Aroutcheva, A, Rice, T, Hota, B (2010) Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 50: pp. 979-87 CrossRef
  15. Popovich, KJ, Hota, B, Aroutcheva, A, Kurien, L, Patel, J, Lyles-Banks, R (2013) Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis 56: pp. 1067-74 CrossRef
  16. Zervou, FN, Zacharioudakis, IM, Ziakas, PD, Rich, JD, Mylonakis, E (2014) Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis. Clin Infect Dis 59: pp. 1302-11 CrossRef
  17. Vyas, KJ, Shadyab, AH, Lin, CD, Crum-Cianflone, NF (2014) Trends and factors associated with initial and recurrent methicillin-resistant Staphylococcus aureus (MRSA) skin and soft-tissue infections among HIV-infected persons: an 18-year study. J Int Assoc Provid AIDS Care 13: pp. 206-13 2325957412473780" target="_blank" title="It opens in new window">CrossRef
  18. Kazem, S, Meijden, E, Feltkamp, MC (2013) The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS 121: pp. 770-82 2092" target="_blank" title="It opens in new window">CrossRef
  19. Ehlers, B, Wieland, U (2013) The novel human polyomaviruses HPyV6, 7, 9 and beyond. APMIS 121: pp. 783-95 2104" target="_blank" title="It opens in new window">CrossRef
  20. Dalianis, T, Hirsch, HH (2013) Human polyomaviruses in disease and cancer. Virology 437: pp. 63-72 2012.12.015" target="_blank" title="It opens in new window">CrossRef
  21. Wieland, U, Silling, S, Hellmich, M, Potthoff, A, Pfister, H, Kreuter, A (2014) Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. J Gen Virol 95: pp. 928-32 259-0" target="_blank" title="It opens in new window">CrossRef
  22. Rogers, HD, Macgregor, JL, Nord, KM, Tyring, S, Rady, P, Engler, DE (2009) Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 60: pp. 315-20 2008.08.035" target="_blank" title="It opens in new window">CrossRef
  23. Vicente, A, Pau-Charles, I, Gonz谩lez-Ense帽at, MA, Mu帽oz-Almagro, C, Ca帽adas, MP, Noguera-Julian, A (2013) High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. J Am Acad Dermatol 68: pp. 343-5 2012.08.026" target="_blank" title="It opens in new window">CrossRef
  24. Jacobelli, S, Laude, H, Carlotti, A, Rozenberg, F, Deleuze, J, Morini, JP (2011) Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol 147: pp. 590-6 2010.399" target="_blank" title="It opens in new window">CrossRef
  25. Valeyrie-Allanore, L, Sassolas, B, Roujeau, JC (2007) Drug-induced skin, nail and hair disorders. Drug Saf 30: pp. 1011-30 2165/00002018-200730110-00003" target="_blank" title="It opens in new window">CrossRef
  26. Rzany, B, Mockenhaupt, M, Stocker, U, Hamouda, O, Sch枚pf, E (1993) Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol 129: pp. 1059 290135026" target="_blank" title="It opens in new window">CrossRef
  27. Dziuban, EJ, Hughey, AB, Stewart, DA, Blank, DA, Kochelani, D, Draper, HR (2013) Stevens-Johnson syndrome and HIV in children in Swaziland. Pediatr Infect Dis J 32: pp. 1354-8 29ec8e5" target="_blank" title="It opens in new window">CrossRef
  28. Saka, B, Barro-Traor茅, F, Atadokp茅d茅, FA, Kobangue, L, Niamba, PA, Ad茅gbidi, H (2013) Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol 52: pp. 5 2.2012.05743.x" target="_blank" title="It opens in new window">CrossRef
  29. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol. 2007.
  30. Azukizawa, H, Sano, S, Kosaka, H, Sumikawa, Y, Itami, S (2005) Prevention of toxic epidermal necrolysis by regulatory T cells. Eur J Immunol 35: pp. 1722-30 2/eji.200425773" target="_blank" title="It opens in new window">CrossRef
  31. Smith, KJ, Skelton, HG, Yeager, J, Ledsky, R, Ng, TH, Wagner, KF (1997) Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Clin Exp Dermatol 22: pp. 118-23 2230.1997.tb01038.x" target="_blank" title="It opens in new window">CrossRef
  32. Yang, C, Mosam, A, Mankahla, A, Dlova, N, Saavedra, A (2014) HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. J Am Acad Dermatol 70: pp. 1096-102 2013.12.025" target="_blank" title="It opens in new window">CrossRef
  33. Brock, MV, Hooker, CM, Engels, EA, Moore, RD, Gillison, ML, Alberg, AJ (2006) Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 43: pp. 47-55 232260.95288.93" target="_blank" title="It opens in new window">CrossRef
  34. Puoti, M, Bruno, R, Soriano, V, Donato, F, Gaeta, GB, Quinzan, GP (2004) Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 18: pp. 2285-93 2030-200411190-00009" target="_blank" title="It opens in new window">CrossRef
  35. Grulich, AE, Leeuwen, MT, Falster, MO, Vajdic, CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: pp. 59-67 2" target="_blank" title="It opens in new window">CrossRef
  36. Grabar, S, Abraham, B, Mahamat, A, Giudice, P, Rosenthal, E, Costagliola, D (2006) Differential impact of combination antiretroviral therapy in preventing Kaposi鈥檚 sarcoma with and without visceral involvement. J Clin Oncol 24: pp. 3408-14 200/JCO.2005.05.4072" target="_blank" title="It opens in new window">CrossRef
  37. Polesel, J, Franceschi, S, Suligoi, B (2010) Cancer incidence in people with AIDS in Italy. Int J Cancer 127: pp. 1437-45 2/ijc.25153" target="_blank" title="It opens in new window">CrossRef
  38. Franceschi, S, Lise, M, Clifford, GM, Rickenbach, M, Levi, F, Maspoli, M (2010) Swiss HIV Cohort Study. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 103: pp. 416-22 CrossRef
  39. Hleyhel, M, Belot, A, Bouvier, AM (2013) Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis 57: pp. 1638-47 CrossRef
  40. Rogers, HW, Weinstock, MA, Harris, AR, Hinckley, MR, Feldman, SR, Fleischer, AB (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146: pp. 283-7 2010.19" target="_blank" title="It opens in new window">CrossRef
  41. Webb, MC, Compton, F, Andrews, PA, Koffman, CG (1997) Skin tumours posttransplantation: a retrospective analysis of 28 years鈥?experience at a single centre. Transplant Proc 29: pp. 828-30 2-2" target="_blank" title="It opens in new window">CrossRef
  42. Euvrard, S, Kanitakis, J, Claudy, A (2003) Skin cancers after organ transplantation. N Engl J Med 348: pp. 1681-91 22137" target="_blank" title="It opens in new window">CrossRef
  43. Silverberg, MJ, Leyden, W, Warton, EM, Quesenberry, CP, Engels, EA, Asgari, MM (2013) HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst 105: pp. 350-60 29" target="_blank" title="It opens in new window">CrossRef
  
• 刊物主题：Infectious Diseases;
• 出版者：Springer US
• ISSN：1534-3146

文摘

Dermatologic diseases are common in the HIV-infected population. Many of the cutaneous diseases are not unique to this group, but the presentation can be more severe. Although the introduction of antiretroviral therapy has been followed by a decline in many of the skin diseases associated with HIV, drug reactions and other non-infectious skin conditions have increased. This article reviews the current spectrum of HIV-associated skin conditions, focusing on common complaints, infections, drug-associated toxicity and malignancies.